(date)                                                             FILE NUMBER: 

                                                                        NAME OF EMPLOYEE: 

(Claimant name)

(Claimant address)

(Claimant address)

 

Dear Claimant:

 

Our records indicate that you have a claim for compensation under the Energy Employees Occupational Illness Compensation Program Act (EEOICPA) that received a radiation dose reconstruction at the National Institute for Occupational Safety and Health (NIOSH). 

 

I am writing to inform you that on [enter effective date of PER], NIOSH issued [OCAS-PER-022 “Chapman Valve TBD Revision,” OCAS-PER-023 “Argonne National Lab – West TBD Revision,” OCAS-PER-024 “General Steel Industries TBD Approval,” OCAS-PER-025 “Huntington Pilot Plant TBD Revision,” as appropriate].  The changes identified in the report affect the dose reconstruction methodology by which a dose reconstruction is conducted. 

 

The Division of Energy Employees Occupational Illness Compensation is obligated to ensure that the application of the dose reconstruction methodology is administered in a fair and consistent manner.  As a result of changes made by NIOSH, the prior dose reconstruction and the percentage used to establish the compensability on your claim may be invalid.  While the modification may or may not impact the outcome of your claim, it is necessary for your claim to undergo a new dose reconstruction in order to make that determination.  Accordingly, I am returning your case to NIOSH.

 

Once the revised dose reconstruction is complete, you will have the opportunity to review the dose reconstruction report, and will again be required to sign the NIOSH OCAS-1 form to acknowledge your receipt of the revised report and dose reconstruction results. 

 

I will then use the information from the revised dose reconstruction to recalculate the percentage to determine whether the claimed cancer(s) was at least as likely as not (50% or greater) related to the covered employment. 

 

Again, the change described above does not mean that your claim will be approved; it simply requires that your dose reconstruction be redone using the new guidance.  NIOSH will inform you of the results of that new dose reconstruction, and a new decision will be issued on your claim, using the new dose reconstruction. 

 

If you have specific questions regarding the changes or the status of the dose reconstruction, you may contact the NIOSH office located in Cincinnati, Ohio at 800-232-4636.  Any other questions should still be addressed to this office.

 

Sincerely,

 

 

(Claims Examiner)

 

cc:  NIOSH Public Health Advisor